Novan
Novan is a clinical-stage drug development company developing deliverable nitric oxide.
Business Model:
Revenue: $0
Employees: 51-500
Rankings
Industries / Tags:
Detailed Novan Information
Geographic Data
Address:
City: Morrisville
State: North Carolina
Zip:
Country: United States
Financial Info
Stage:
post ipo equity
Raised Last:
$40M
Raised Total:$210M
Social
Metrics
6,326,995Website Global Rank
997Website Monthly Traffic
Twitter Followers
Description
Novan develops products that tap the anti-bacterial properties of nitric oxide by encapsulating the compound in nano-particles that deliver therapeutic agents to desired body location. They use its proprietary nitric oxide-based science and technology platform to develop innovative, first-in-class therapies for unmet medical needs. The company is committed to using the power of the human body to create safe and effective treatments. They complement their internal scientific talent with strategic partners around the globe to enable Novan to harness the power of nitric oxide and develop technologies that will help address currently untreated and under-treated medical conditions. It was incorporated in 2008 and is based in Morrisville, North Carolina.
Contact Phone:
Contact Email:
Novan went public on 9/21/2016 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
9/21/2016
Ticker Symbol:
NOVN
IPO Price:
$11/share
Amount Raised:
$45M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2015 | Private Equity Round | 1 | $50M |
Malin Corporation Malin Corporation Malin Corporation Malin Corporation |
9/2019 | Grant | 1 | $1.1M |
U.S. Department of Defense U.S. Department of Defense U.S. Department of Defense U.S. Department of Defense |
7/2009 | Venture Round | $2M | 1/2011 | Venture Round | $4M | 4/2019 | Post-IPO Equity | $35M | 6/2021 | Post-IPO Equity | $40M | 9/2019 | Post-IPO Equity | $0 |
Aspire Capital Partners LLC Aspire Capital Partners LLC Aspire Capital Partners LLC Aspire Capital Partners LLC |
3/2014 | Debt Financing | $3.5M | 12/2015 | Venture Round | $32.8M | 10/2011 | Series C | $6M | 2/2013 | Venture Round | $11M | 9/2019 | Post-IPO Equity | 1 | $25M |
Aspire Capital Partners LLC Aspire Capital Partners LLC Aspire Capital Partners LLC Aspire Capital Partners LLC |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 3/2022 | EPI Health |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
